A number of studies using transgenic approaches and pharmacological interventions have shown that PPARδ also plays a crucial role in cardiomyocyte growth and survival, thus suggesting that PPARδ activation may be a therapeutic target in heart diseases [22]. The gene discussed is PPARD; the disease is heart disorder.